| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2019↕ | FY 2018↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.3B | $4.2B | $4.1B | $4.1B | $4.1B | $1.0B | $0.8B | $3.1B |
| Cost of Revenue | $3.2B | $3.1B | $3.0B | $3.0B | $2.8B | $0.7B | $0.6B | $0.6B |
| Gross Profit | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B | $0.3B | $0.2B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.0B | $0.9B | $0.9B | $0.9B | $1.2B | $0.3B | $0.2B | $0.2B |
| Net Income | $0.5B | $0.5B | $0.5B | $0.6B | $0.8B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $3.83 | $3.57 | $3.57 | $3.58 | $4.79 | $1.17 | $1.07 | $1.32 |
| EPS (Diluted) | $3.80 | $3.53 | $3.53 | $3.53 | $4.72 | $1.15 | $1.04 | $1.29 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2019↕ | FY 2018↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.7B | $17.4B | $16.4B | $15.1B | $15.7B | $14.5B | $12.7B | $12.9B |
| Current Assets | $0.4B | $0.4B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.5B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.7B | $0.7B | $0.7B | $0.8B | $0.7B | $0.8B | $0.6B | $0.8B |
| Stockholders' Equity | $1.6B | $1.7B | $1.5B | $1.7B | $1.9B | $1.8B | $1.6B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2019↕ | FY 2018↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.9B | $0.9B | $0.8B | $0.9B | $0.8B | $0.6B | $0.5B |
| Investing Cash Flow | $-0.5B | $-0.6B | $-0.5B | $-0.4B | $-0.4B | $-0.3B | $-0.4B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.4B | $-0.4B | $-0.5B | $-0.5B | $-0.3B | $-0.1B |